UA92498C2 - Каннабиноидно активный фармацевтический ингредиент для улучшенных дозированных форм - Google Patents

Каннабиноидно активный фармацевтический ингредиент для улучшенных дозированных форм

Info

Publication number
UA92498C2
UA92498C2 UAA200800554A UAA200800554A UA92498C2 UA 92498 C2 UA92498 C2 UA 92498C2 UA A200800554 A UAA200800554 A UA A200800554A UA A200800554 A UAA200800554 A UA A200800554A UA 92498 C2 UA92498 C2 UA 92498C2
Authority
UA
Ukraine
Prior art keywords
active pharmaceutical
pharmaceutical ingredient
dosage forms
cannabinoid active
tetrahydrocannabinol
Prior art date
Application number
UAA200800554A
Other languages
English (en)
Ukrainian (uk)
Inventor
Роберт Дж. Куппер
Original Assignee
Евро-Селтик С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Евро-Селтик С.А. filed Critical Евро-Селтик С.А.
Publication of UA92498C2 publication Critical patent/UA92498C2/ru

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Описаны фармацевтические композиции, которые включают каннабиноидно активный фармацевтический ингредиент, кристаллический транс-(±)-Δ-тетрагидроканнабинол, и их составы. Изобретение также касается способов лечения или профилактики состояния, такого как боль, которые включают введение нуждающемуся в этом пациенту эффективного количества кристаллического транс-(±)-Δ-тетрагидроканабинола.В определенных вариантах осуществления, кристаллический транс-(±)-Δ-тетрагидроканнабинол, применяемый согласно способам лечения или профилактики состояния, такого как боль, может иметь чистоту, по крайней мере, приблизительно 98 % от общего количества каннабиноидов.
UAA200800554A 2005-06-16 2006-06-14 Каннабиноидно активный фармацевтический ингредиент для улучшенных дозированных форм UA92498C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69136105P 2005-06-16 2005-06-16

Publications (1)

Publication Number Publication Date
UA92498C2 true UA92498C2 (ru) 2010-11-10

Family

ID=39548322

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200800554A UA92498C2 (ru) 2005-06-16 2006-06-14 Каннабиноидно активный фармацевтический ингредиент для улучшенных дозированных форм

Country Status (4)

Country Link
CN (1) CN101198324B (ru)
ES (1) ES2357250T3 (ru)
UA (1) UA92498C2 (ru)
ZA (1) ZA200709788B (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8758826B2 (en) * 2011-07-05 2014-06-24 Wet Inc. Cannabinoid receptor binding agents, compositions, and methods
ES2616887T3 (es) * 2013-10-29 2017-06-14 Echo Pharmaceuticals B.V. Comprimido que contiene delta 9-tetrahidrocannabinol, método para su producción y uso de tal comprimido en el tratamiento oral
AU2015280412B2 (en) 2014-06-26 2018-07-26 Island Breeze Systems Ca, Llc MDI related products and methods of use
CA3072768C (en) 2017-08-27 2024-06-11 Rhodes Technologies Pharmaceutical compositions for the treatment of ophthalmic conditions
CN112752556A (zh) * 2018-04-27 2021-05-04 雷米生物科学公司 新的医疗装置、递送运载体及其制造
CN109970516A (zh) * 2019-03-20 2019-07-05 栾云鹏 一种工业化制备高纯度高收率的大麻酚类物质的合成方法
CN111943813B (zh) * 2019-05-17 2023-04-14 上海特化医药科技有限公司 大麻二酚类化合物的制备方法
CN110200953B (zh) * 2019-06-15 2022-02-08 汉义生物科技（北京）有限公司 大麻素在制备吸入给药药物中的应用
WO2022140245A1 (en) * 2020-12-21 2022-06-30 Isosceles Pharmaceuticals, Inc. Parenteral cannabinoid formulations and uses thereof
CN113173857B (zh) * 2021-03-09 2023-05-23 昆明理工大学 一种大麻二酚衍生物及其制备方法与应用
CN113440508B (zh) * 2021-07-27 2023-10-27 昆明理工大学 大麻二酚衍生物的新应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US6509005B1 (en) * 1998-10-27 2003-01-21 Virginia Commonwealth University Δ9 Tetrahydrocannabinol (Δ9 THC) solution metered dose inhaler
ES2280343T3 (es) * 2000-03-09 2007-09-16 Gw Pharma Limited Composiciones farmaceuticas que contienen cannabis.

Also Published As

Publication number Publication date
ES2357250T3 (es) 2011-04-20
CN101198324A (zh) 2008-06-11
CN101198324B (zh) 2011-06-08
ZA200709788B (en) 2008-08-27

Similar Documents

Publication Publication Date Title
MY140576A (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms
TW200633695A (en) Methods for purifying trans-(-)-Δ9-tetrahydrocannabinol and trans-(+)-Δ9-tetrahydrocannabinol
MXPA04004842A (es) Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1.
MXPA04004837A (es) Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
IL161154A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
AU2003301190A1 (en) Administration of capsaicinoids
WO2005065069A3 (en) Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
WO2001090091A8 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
MXPA04012998A (es) Modulares de receptores nucleares de hormonas esteroideas triciclicos.
EP1299374A4 (en) NEW NON PSYCHOTROPICAL CANNABINOIDS
AU2003225617A1 (en) Thiadiazolylpiperazine derivatives useful for treating or preventing pain
PL373276A1 (en) Trans-epicutaneous administration form for treating restless leg syndrome
WO2008023016A3 (en) Galenic formulations of aliskiren
SE9901573D0 (sv) New compounds
WO2004100893A3 (en) Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
WO2006115770A3 (en) Orally disintegrating pharmaceutical tablet formulations of olanzapine
SE9901572D0 (sv) New compounds
WO2005082413A3 (en) Ciclesonide and glycopyrronium combination
SG146631A1 (en) Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep
MXPA04005033A (es) Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes.
TW200740440A (en) Novel combinations of medicaments for the treatment of respiratory diseases containing long-acting beta-agonists and at least one additional active ingredient
CA2489705A1 (en) Use of amide derivative of ge 2270 factor a3 for the treatment of acne
WO2003043632A3 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer
MXPA04002099A (es) Composiciones medicinales para neuropatia diabetica.
WO2006089120A3 (en) Compositions, methods of use and preparation of 2,6-diisopropyl phenol and analogs for ischemic injury